Theranos halts Zika test

The positive from this rejection is that possibly OPKO can look at this rejection and MAKE SURE they do not have the same or a similar issue. I am not SURE what is going on at the FDA, maybe many new hires out in the field, but seems there have been far more CRL issuings than approvals in recent months. I can think of a half dozen rejections or delays but only a couple approvals.

I find it hard to believe that so many big name, and scientific leaders have forgotten the scientific method, or how to do statistical analysis. If the FDA is not rejecting on one of those grounds, seems every manufacturer has a dusty air vent, or an employee who forgot to log a digit during a batch check.

No wonder it is taking so long to get a drug approved, and ramping up the cost of research.

I know Theranos might be a competitor to Claros, but the bottom line will be in the execution and available tests. Once OPKO gets those things right, and approved, I think the National/global footprint of BRLI will become Theranos' biggest problem, and these recent short comings pale in comparison.

FIRST, OPKO DOES NEED get this RIGHT, before, can I say it, the " WAR GAMES " begin,. YOUR MOVE PROFESSOR.